REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours
Ann Oncol
.
2015 Nov;26(11):2359.
doi: 10.1093/annonc/mdv386.
Authors
C Lévy
1
,
D Allouache
1
,
J Lacroix
2
,
A E Dugué
3
,
S Supiot
1
,
M Campone
1
,
M Mahe
4
,
S Kichou
5
,
M Leheurteur
1
,
C Hanzen
6
,
V Dieras
1
,
Y Kirova
7
,
F Campana
7
,
E Le Rhun
1
,
L Gras
8
,
T Bachelot
1
,
M-P Sunyach
9
,
I Hrab
1
,
J Geffrelot
10
,
K Gunzer
11
,
J-M Constans
12
,
J-M Grellard
3
,
B Clarisse
3
,
X Paoletti
13
Affiliations
1
Department of Oncology.
2
Department of Radiology, Centre François Baclesse, Caen Department of GIP Cyceron, Caen.
3
Department of Clinical Research, Centre François Baclesse, Caen.
4
Department of Radiotherapy, Institut de Cancérologie de l'Ouest René Gauducheau, Nantes-Saint Herblain, Caen.
5
Department of Radiology, Centre François Baclesse, Caen.
6
Department of Radiotherapy, Centre Henri Becquerel, Rouen.
7
Department of Radiotherapy, Institut Curie, Paris.
8
Department of Radiotherapy, Centre Oscar Lambret, Lille.
9
Department of Radiotherapy, Centre Léon Bérard, Lyon.
10
Department of Radiotherapy, Centre François Baclesse, Caen.
11
Department of Oncology Department of Clinical Research, Centre François Baclesse, Caen.
12
Department of GIP Cyceron, Caen Department of Radiology, Centre Hospitalier Universitaire, Caen.
13
Department of Biostatistics, Institut Curie/Inserm U900, Paris, France.
PMID:
26504187
DOI:
10.1093/annonc/mdv386
No abstract available
Publication types
Published Erratum